GlassScriptPhysician profile
Erin M Griffith
NPI 1912352915
$386.94
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $387.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $126.38 | 2022 | |
| Abbvie INC. | $58.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.77 | 2022 | |
| Merck Sharp & Dohme LLC | $40.70 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.01 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.61 | 2022 | |
| Jazz Pharmaceuticals INC. | $18.30 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.50 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.14 | 2022 | |
| Lilly USA, LLC | $12.24 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.